China Propofol Market Research Report 2021-2025


DUBLIN, January 07, 2022–(BUSINESS WIRE)–The “China Propofol Market Investigation Report 2021-2025” report has been added to from offer.

According to the market research, the sales of propofol in the Chinese market increased year by year from 2016 to 2019. Due to the impact of the new corona epidemic on the entire diagnostic and treatment services medical products, sales decreased from 1.232 billion yuan in 2019 to 1.308 billion CNY in 2020, with a decline of 14.28% year-on-year. The CAGR of Propofol sales in China from 2016 to 2020 is 1.89%.

Propofol is a short-acting intravenous anesthetic. Its uses include induction and maintenance of general anesthesia, sedation for mechanically ventilated adults, and procedural sedation. It is also used for status epilepticus if other medicines have not worked. Its product was developed by Fresenius Kabi Deutschland GmbH.

Propofol was approved for clinical use in China in 1994 and is currently included in Chinese medical insurance. In the first half of 2021, there were 7 manufacturers in the Chinese Propofol market, among which Fresenius Kabi Deutschland GmbH accounts for the largest market share.

The analyst expects Propofol sales to experience restorative growth from 2021 to 2025 with the effective easing of the new corona outbreak. Additionally, propofol has a rapid onset, stable induction, and rapid and complete recovery. Based on these advantages, the sales volume of Propofol will steadily increase in the future.

Additionally, Propofol is also used in veterinary clinical anesthesia. With the expansion of the pet market in China and the servitization and standardization of pet hygiene, Propofol will also expand into the pet medicine market, leading to the growth of its sales and its sales volume.

Topics Covered:

  • The impact of COVID-19 on the Chinese propofol market

  • Chinese Propofol Sales Value 2016-2020

  • Competitive Landscape of China Propofol Market

  • Propofol price in China

  • Propofol Price in China by Regions and Manufacturers

  • Analysis of factors affecting the development of the Chinese Propofol market

  • China Propofol Market Outlook 2021 to 2025

Main topics covered:

1 Relevant concept of propofol

1.1 Propofol indications

1.2 Development of Propofol in China

1.3 Government approval of propofol in China

1.4 The impact of COVID-19 on Propofol sales in China

2 China Propofol Sales, 2016-2020

2.1 Propofol Sales Value

2.1.1 Overall sales value

2.1.2 Sales Value by Region

2.2 Propofol Sales Volume

2.2.1 Overall Sales Volume

2.2.2 Sales Volume by Region

2.3 China Propofol Sales by Dosage Form, 2016-2020

2.3.1 Injection

2.3.2 Analysis of other dosage forms

3 Analysis of Propofol Key Manufacturers in China in 2020

3.1 Propofol Key Manufacturers Market Share Analysis

3.1.1 Market Share Survey by Sales Value

3.1.2 Market Share Survey by Sales Volume

3.2 Fresenius Kabi Deutschland GmbH

3.2.1 Company profile

3.2.2 Sales of PROPOFOL 1% FRESENIUS AND PROPOFOL 2% FRESENIUS (Propofol by Fresenius Kabi Deutschland GmbH) in China

3.3 Aspen Pharma Trading Ltd

3.3.1 Company Profile

3.3.2 DIPRIVAN (Propofol by Aspen Pharma Trading Ltd) Sales in China

3.4 Sichuan Guorei Pharmaceutical Co., Ltd.

3.4.1 Company Profile

3.4.2 China Leweijing (Sichuan Guorei Pharmaceutical Co.,Ltd. Propofol) Sales

3.5 Guangdong Jiabo Pharmaceutical Co., Ltd.

3.5.1 Business Profile

3.5.2 China Dishining (Guangdong Jiabo Pharmaceutical Co., Ltd. Propofol) Sales

3.6 Xian Libang Pharmaceutical Co., Ltd.

3.6.1 Company Profile

3.6.2 China Limengxin (Xian Libang Pharmaceutical Co., Ltd. Propofol) Sales

4 Propofol Price for Different Manufacturers in China, 2020-2021

4.1 Fresenius Kabi Deutschland GmbH (PROPOFOL 1% FRESENIUS AND PROPOFOL 2% FRESENIUS)

4.2 Aspen Pharma Trading Ltd (DIPRIVAN)

4.3 Sichuan Guorei Pharmaceutical Co., Ltd. (Leweijing)

4.4 Guangdong Jiabo Pharmaceutical Co., Ltd. (Dishing)

4.5 Xian Libang Pharmaceutical Co., Ltd. (Limengxin)

5 China Propofol Market Outlook, 2021-2025

5.1 Influencing Factors of China Propofol Market Development

5.1.1 The impact of COVID-19 on the Chinese Propofol market

5.1.2 Market Drivers and Opportunities

5.1.3 Market Threats and Challenges

5.2 Market Size Forecast

5.3 Market Trend Forecast

For more information on this report, visit

See the source version on

Laura Wood, Senior Press Officer
[email protected]
For EST business hours, call 1-917-300-0470
For US/CAN call toll free 1-800-526-8630
For GMT office hours call +353-1-416-8900


Comments are closed.